Assessment of patients with primary Sjögren's syndrome-outcome over 10 years using the Sjögren's Syndrome Damage Index

Rheumatology

Volumn 49, Issue 8, 2010, Pages 1559-1562

  Krylova, Lada ^a   Isenberg, David ^a  

^a UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

Malignancy; Non Hodgkin's lymphoma; Parotid swelling; Sj gren's syndrome

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PRIORITY JOURNAL; SJOEGREN SYNDROME; SJOEGREN SYNDROME DAMAGE INDEX; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HEALTH STATUS; HUMANS; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; PAROTID DISEASES; SEVERITY OF ILLNESS INDEX; SJOGREN'S SYNDROME; TIME FACTORS; YOUNG ADULT;

EID: 77954737366     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/keq086     Document Type: Article

References (13)

1. Jonsson R, Bowman SJ, Gordon TP. Sjögren's syndrome. Ch. 78. In: Koopman WJ, Moreland LW, eds, Arthritis and allied conditions. 15th edition. Lippincott: Williams and Wilkins, 2005:1681-705.
2. Skopouli FN, Urania D, Ioannidis JPA. Clinical evolution, and morbidity and mortality of primary Sjögren's syndrome. Semin Arthritis Rheum 2000;29:296-304.
3. Theander E, Andersson SI, Manthorpe R, Jacobsson LH. Proposed core set of outcome measures in patients with primary Sjögren's syndrome: 5 year follow-up. J Rheumatol 2005;32:109-16.
4. Barry RJ, Sutcliffe N, Isenberg DA et al. The Sjogren's Syndrome Damage Index-a damage index for use in clinical trials and observational studies in primary Sjogren's syndrome. Rheumatology 2008;47:1193-8.
5. Stoll T, Seifert B, Isenberg DA. SLICC/ACR damage index is valid, and renal and pulmonary organ scores are predictors of severe outcome in patients with systemic lupus erythematosus. Br J Rheumatol 1996;35: 248-54.
6. Gladman DD, Ginzler E, Goldsmith C et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 1996;39:363-9.
7. Gladman DD, Urowitz MB. The SLICC/ACR damage index: progress report and experience in the field. Lupus 1999;8:632-7.
8. Dayal NA, Gordon C, Tucker L, Isenberg DA. The SLICC damage index: past, present and future. Lupus 2002;11:261-5.
9. Gladman DD, Urowitz M, Goldsmith C et al. The reliability of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index in patients with systemic lupus erythematosus. Arthritis Rheum 1997;40:809-13.
10. Gladman DD, Goldsmith CH, Urowitz MB et al. The Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ACR) damage index for systemic lupus erythematosus international comparison. J Rheumatol 2000;27:373-6.
11. Vitali C, Bombardieri S, Jonsson R et al. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;61:554-8.
12. Voulgarelis M, Tzioufas AG, Moutsopoulos HM. Mortality in Sjögren's syndrome. Clin Exp Rheumatol 2008; 26(5 Suppl. 51):S66-71.
13. ISD Cancer Information Programme. Cancer statistics. Non-Hodgkin's Lymphoma: ICD-10 C82-C85. http://www.isdscotland.org/isd/1483.html Cancer prevalence (15 December 2009, date last accessed).